Ocugen (OCGN) EBITDA Margin (2020 - 2026)
Ocugen (OCGN) recorded EBITDA Margin of -1065.73% in Q2 2026, down 151.38 percentage points from -914.35% a year earlier but up 59.45 percentage points from the prior quarter.
Powered by 
Analysis
Ocugen (OCGN) EBITDA Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Ocugen's EBITDA Margin came in at -1466.68% as of Jun 30, 2026, down 365.69 percentage points year-over-year; for FY2025, it came in at -1371.56%, down 69.74 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +47891.23 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -1301.82% in FY2024 (-227.82 pp), -1074.01% in FY2023 (+2486.73 pp) and -3560.73% in FY2022.
- Quarterly EBITDA Margin has ranged from -5358.15% in Q3 2022 to -331.28% in Q3 2023 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in three of the last seven quarters, with an average year-over-year change of -178.43 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 5026.88 percentage points in Q3 2023, against a drop of 1476.21 percentage points in Q2 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Ocugen | 322.34 Mn | 87.56 Mn | - | -842.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -842.29% |
| Jun 30, 2026 | -981.65% |
| Mar 31, 2026 | -1,099.09% |
| Sep 30, 2025 | -951.77% |
| Jun 30, 2025 | -937.22% |
| Mar 31, 2025 | -917.76% |
| Dec 31, 2024 | -1,733.25% |
| Sep 30, 2024 | -1,112.59% |
| Jun 30, 2024 | -1,303.33% |
| Mar 31, 2024 | -1,187.08% |
| Dec 31, 2023 | -805.25% |
| Sep 30, 2023 | -331.28% |
| Jun 30, 2023 | -4,817.73% |
| Mar 31, 2023 | -4,031.83% |
| Dec 31, 2022 | -2,637.32% |
| Sep 30, 2022 | -5,358.15% |
| Jun 30, 2022 | -3,341.52% |
| Mar 31, 2022 | -3,790.80% |
| Jun 30, 2020 | -7,781.40% |
API Access
Ocugen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OCGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "OCGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OCGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();